Pfizer (PFE) in Global Blood Therapeutics (GBT) Takeover Talks
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
GBT Announces New Employment Inducement Grants
August 4, 2022 4:05 PM EDTSOUTH SAN FRANCISCO, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc.(GBT) (NASDAQ: GBT) today announced that on August 1, 2022, the compensation committee of GBTs board of directors granted 10 new employees restricted stock units for an aggregate of 30,450 shares of the companys common stock. These awards were made under GBTs Amended and Restated 2017 Inducement Equity Plan (the Plan).Â
The above-described awards were... More
